Potato Starch IR Granules are pharmaceutical-grade granules developed for immediate-release (IR) oral formulation applications. Potato starch is obtained from the tuber of Solanum tuberosum L. and is recognized as a pharmaceutical excipient. It is commonly identified by CAS Number 9005-25-8 and is represented by the polymeric formula (C₆H₁₀O₅)ₙ. As a polymeric material, potato starch does not have one fixed molecular weight.
The term IR Granules refers to the intended immediate-release performance of the finished granule or formulation. Potato starch can contribute to formulation performance through its interaction with water and its established use as a starch-based excipient. However, the actual release behavior of Potato Starch IR Granules depends on the complete formulation, granule characteristics, processing conditions, and any other ingredients incorporated into the finished product.
Potato starch is a naturally derived pharmaceutical excipient used in oral solid formulation development. Starch-based excipients may perform functions such as disintegration, binding, and dilution depending on the material and formulation design.
For Potato Starch IR Granules, the granular format provides a controlled particulate form of potato starch for formulation and processing applications. The finished granules can be evaluated for physical characteristics such as particle size, moisture, bulk density, tapped density, flowability, and granule integrity.
USP emphasizes that excipient performance can depend on material attributes that may not be fully represented by basic compendial specifications and that the effect of an excipient can vary according to the formulation and manufacturing process.
Immediate-release formulations are designed to make the incorporated component available without an intentional sustained- or delayed-release mechanism. For Potato Starch IR Granules, the immediate-release designation should therefore be supported by the finished product's formulation design and appropriate performance testing.
Important factors affecting immediate-release behavior may include:
Specific dissolution times or release percentages should only be stated when supported by validated product-specific testing.
Potato starch has established relevance as a pharmaceutical excipient for oral solid formulations. Starch materials can be used in tablet and capsule formulations for functions including binding, dilution, and disintegration, depending on the grade and formulation requirements.
Potato Starch IR Granules can therefore be considered for formulation systems where a starch-based granular excipient is required. The final role of the granules should be established through formulation development and performance testing.
The physical properties of the finished Potato Starch IR Granules can influence handling, blending, filling, and formulation performance.
Relevant quality attributes may include:
These properties are product-specific. Numerical particle-size ranges, density values, moisture limits, or flowability values should only be published when supported by the actual approved product specification or Certificate of Analysis.
Starch is relevant to pharmaceutical formulation development because of its interaction with water and swelling behavior. In immediate-release tablet systems, the selection and concentration of excipients can influence tablet disintegration and subsequent dissolution.
Research on starch-based pharmaceutical formulations demonstrates that starch characteristics can influence disintegration and dissolution performance.
For Potato Starch IR Granules, the final disintegration and dissolution behavior depends on the complete formulation. Factors such as compression force, tablet hardness, formulation composition, particle size, moisture, and other excipients can influence the result.
Therefore, the term Immediate Release should not be associated with an unsupported universal dissolution time.
Potato Starch IR Granules can be considered for tablet formulation development where a starch-based pharmaceutical excipient is required. Depending on the formulation, the material may contribute to disintegration, binding, or dilution.
During development, formulation scientists may evaluate:
The final acceptance criteria should be established according to the intended product and applicable quality requirements.
Potato Starch IR Granules can also be evaluated in suitable capsule and multiparticulate oral formulations. The granular structure can support controlled handling and blending with other pharmaceutical excipients.
For capsule applications, particle-size distribution, density, flowability, moisture, and compatibility with other formulation components may be important considerations.
Quality control of Pharmaceutical Potato Starch IR Granules should distinguish between the raw potato starch requirements and the finished granule specifications.
USP defines Potato Starch as material obtained from the tuber of Solanum tuberosum L.
Finished-product testing may include:
USP's excipient-performance guidance notes that excipient properties can vary from supplier to supplier and batch to batch and that their impact depends on the formulation and manufacturing process.
Accordingly, finished Potato Starch IR Granules should be controlled using an approved product specification rather than assuming that raw-material specifications define all finished-granule performance characteristics.
A Potato Starch IR Granules Manufacturer in India can develop pharmaceutical-grade potato starch granules for immediate-release formulation applications. Product development may consider the starch source, granulation process, particle-size distribution, moisture, flowability, density, and formulation performance.
For pharmaceutical manufacturing, consistency of the finished granules is important because physical material properties can influence blending, filling, compression, disintegration, and dissolution.
Potato Starch IR Granules can be supplied for pharmaceutical formulation development, tablet manufacturing, capsule formulations, and other suitable oral solid applications.
A Potato Starch IR Granules Supplier in India should provide material according to the applicable product specification, including relevant identity, physical, chemical, and microbiological quality requirements.
The actual immediate-release performance should be established using product-specific formulation and dissolution testing.
Potato Starch IR Granules may be considered for:
The exact function and concentration should be determined during formulation development.
| Parameter | Specification |
|---|---|
| Appearance | White to off-white granules |